Advertisement Lucid granted approval to market reflective microscope - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lucid granted approval to market reflective microscope

Lucid has reported that the China's State Food and Drug Administration has approved the sale of the Lucid VivaScope reflective confocal microscope in the Peoples Republic of China.

Lucid’s VivaScope reflective confocal microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions – without the need for surgery to excise tissue – thus improving the quality of care for their patients. Sales of Lucid’s VivaScope confocal microscopes in China will be handled by ConBio.

Jay Eastman, CEO of Lucid, said: “This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China.”